No internet connection — showing the saved version of the page.

Innate Pharma

FREUR
← to the screener

Innate Pharma (PA:IPH) — Biotechnology: Biological Products (No Diagnostic Substances). Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
innate-pharma.com
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
MARSEILLE, France
CEO
Mr. Jonathan E. Dickinson B.Sc., M.B.A.
Employees
120
Founded
1999
Shares outstanding
111.7 M
Free float
70.45 M
Market cap
146.33 M EUR
Insiders
17.46%
Institutions
10.86%
Industry (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
FR0010331421
Description

Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma; IPH4502, a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4; and Monalizumab, a dual checkpoint inhibitor that targets T Cells and NK Cells. It also develops IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway; IPH6401, an BCMA-targeting NK cell engager; IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. In addition, the company develops IPH6501, a tetra-specific NK cell engager to activate receptors, NKp46 and CD16, tumor antigen (CD20) and an interleukin-2 receptor. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.

Exchanges and tickers

ExchangeTickerCurrencyPriceType
PA Euronext ParisIPH primaryEUR1.266 -3.36%common stock
LSE London Stock Exchange0EVI IOBEUR3.0281 +0.00%common stock
US USA StocksIPHYF OTCUSD1.5092 -8.53%common stock

Price for 3 months

PA:IPH · EUR
up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

No dividend payments found (checked 09.10.2026). The company probably does not pay dividends.

News this week

No news in the last week. Latest news: 17.09.2026.

advertisement

Top holders

HolderStakeSharesReport date
ETF Series Solutions-Ran…0.08%72 6952025-02-28
Lion Point Capital, LP0.07%81 1512026-06-30
Morgan Stanley0.04%43 5242026-06-30
Smartharvest Portfolios,…0.02%23 7502026-06-30
Dimensional ETF Trust-Di…0.02%23 2772026-01-31
Xtx Topco Ltd0.01%15 1302026-06-30
Citadel Advisors Llc0.01%12 4412026-06-30
Jane Street Group, LLC0.01%10 3102026-06-30
Rhumbline Advisers0%4 7192026-06-30
UBS Group AG0%1 3632026-06-30
Farther Finance Advisors…0%212026-06-30
Gamma Investing LLC0%92026-06-30